Notice of Intent to Sole Source Deployed Medicine Services
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) has issued a Notice of Intent to Sole Source a contract to Allogy, LLC for Deployed Medicine Services. This action is to ensure the continued sustainment and development of the Deployed Medicine platform, which is built on Allogy's proprietary Capillary platform. This notice is not a request for competitive proposals or a solicitation.
Scope of Work
The contract will cover a five-year period for the Medical Simulation and Training Program Management Office (MST PMO). Services include:
- Management of the Deployed Medicine platform (formerly Joint Trauma and Education Training Delivery Platform - JTETDP).
- Software configuration control and sustainment.
- Content updates and cloud hosting services.
- Technical and help desk support.
- Incorporation of new capabilities as required.
Contract & Timeline
- Type: Special Notice (Notice of Intent to Sole Source)
- Duration: Five (5) years
- Set-Aside: Total Small Business Set-Aside (FAR 19.5)
- Response Due: June 18, 2026, 5:00 PM UTC
- Published: June 3, 2026
Additional Notes
This is explicitly not a request for competitive proposals, and no solicitation package is available. Any responses submitted will be reviewed by military personnel, government civilians, and support contractors, but no feedback will be provided, and submissions become DHA property. Telephone inquiries will not be accepted.